A generic alternative indicated for Neurology and Digestive Health. This clinical formulation manages vestibular system signaling to reduce the frequency and severity of vertigo attacks.
Indicated to address symptoms of Meniere's disease by improving inner ear circulation to alleviate vertigo and mitigate persistent ringing and hearing loss.
Mechanism of Action
Betahistine works by improving blood flow in the inner ear and reducing pressure buildup. It acts on histamine receptors to help the brain process balance signals more effectively and reduce dizziness.
Route of Administration
Oral
Onset Time
Days to weeks
Duration
8–12 hours
Contraindications
Pheochromocytoma, Active peptic ulcer, Hypersensitivity to betahistine, Asthma (caution)
Severe Adverse Events
Severe allergic reactions, Bronchospasm, Internal bleeding (ulcer exacerbation), Sudden swelling
Common Side Effects
Mild headache
Uncommon Side Effects
Nausea, Indigestion, Bloating, Skin rash
Drug Interactions
Antihistamines, MAOIs
Pregnancy Safety Warnings
Not recommended during pregnancy or breastfeeding.
Information for Betahistine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
